0001231919-26-001113.txt : 20260828 0001231919-26-001113.hdr.sgml : 20260828 20260828123119 ACCESSION NUMBER: 0001231919-26-001113 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260828 DATE AS OF CHANGE: 20260828 EFFECTIVENESS DATE: 20260828 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DalCor Pharmaceuticals US, LLC CENTRAL INDEX KEY: 0001673368 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-595783 FILM NUMBER: 261337279 BUSINESS ADDRESS: STREET 1: 400 S. EL CAMINO REAL, SUITE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402 BUSINESS PHONE: 650-401-2000 MAIL ADDRESS: STREET 1: 400 S. EL CAMINO REAL, SUITE 1200 CITY: SAN MATEO STATE: CA ZIP: 94402 D 1 primary_doc.xml X0708 D LIVE 0001673368 DalCor Pharmaceuticals US, LLC 677 North Washington Blvd Suite 132 Sarasota FL FLORIDA 34236 514 508-5099 DELAWARE None None Limited Liability Company true Douglas Michael Dixon c/o DalCor Pharmaceuticals US, LLC 677 North Washington Blvd, Suite 132 Sarasota FL FLORIDA 34236 Director Paul Fonteyne c/o DalCor Pharmaceuticals US, LLC 677 North Washington Blvd, Suite 132 Sarasota FL FLORIDA 34236 Director Pharmaceuticals Decline to Disclose 06b false 2026-07-30 false true false 0 6958236 6958236 0 false 8 0 0 0 false DalCor Pharmaceuticals US, LLC /s/ Douglas Michael Dixon Douglas Michael Dixon Manager 2026-08-28